Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?

Miners, A; (2014) Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective? Sexually transmitted infections, 90 (2). p. 82. ISSN 1368-4973 DOI: https://doi.org/10.1136/sextrans-2013-051428

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/sextrans-2013-051428

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar